Report updated Apr 29, 2026
Clinical Pharmacology by CK
For healthcare professionals and clinicians requiring point-of-care access to drug information.
Overview · Full Intel report in progress
Clinical Pharmacology by CK is an established medical app that is completely free. With a 2.1/5 rating from 11 reviews, it shows polarized user reception.
What is Clinical Pharmacology by CK?
Current Momentum
v1.0
No release notes available.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
A search functionality designed to provide rapid access to trusted clinical evidence.
Provides drug information updates, including availability during weekends and holidays.
Allows users to sign in securely using existing Clinical Pharmacology or institutional credentials.
How much does it cost?
Who Built It?
Elsevier
Providing medical and academic professionals with digital access to essential textbooks, clinical reference tools, and secure assessment platforms.
Portfolio
12
Apps
What other apps does Elsevier make?
Explore the full Elsevier report
Portfolio breakdown, audience, momentum, and every app published by Elsevier.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for Clinical Pharmacology by CK?
How's The Medical Market?
Market outlook for this category
Available very soon
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Clinical Pharmacology by CK
Key Takeaways
While marketed as a productivity tool for clinicians, user feedback suggests the app may function primarily as a mobile-web wrapper, leading to concerns regarding its native app performance.
Where Is It Heading?
Trend analysis
Available very soon